The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa; results of a prospective European cohort study

Activity and components of the G-CSF pathway in hidradenitis suppurativa

Differential Profiles of Gamma-Secretase-Notch Signaling in Hidradenitis Suppurativa: The Need for Genotype-Endotype-Phenotype Analysis

Drug survival of Adalimumab and Infliximab in Hidradenitis Suppurativa Patients: A Daily Practice Cohort Study

Hepatitis B and C among patients with hidradenitis suppurativa: a population-based study

Comorbidity screening in Hidradenitis Suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations

Hidradenitis suppurativa and chromosomal abnormalities: a case report and systematic review of the literature

Treatment of hidradenitis suppurativa with tetracycline, doxycycline, or lymecycline: a prospective study

Clinical Epidemiology and Management of Hidradenitis Suppurativa

Potential Predictive Biomarkers of Adalimumab Response in Patients with Hidradenitis Suppurativa.